IRIS Accounts Production v26.2.0.496 14140139 Board of Directors 1.1.25 31.12.25 31.12.25 12.8.26 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 14140139 2024-12-31 14140139 2025-12-31 14140139 2025-01-01 2025-12-31 14140139 2023-12-31 14140139 2024-01-01 2024-12-31 14140139 2024-12-31 14140139 ns15:EnglandWales 2025-01-01 2025-12-31 14140139 ns14:PoundSterling 2025-01-01 2025-12-31 14140139 ns10:Director1 2025-01-01 2025-12-31 14140139 ns10:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14140139 ns10:SmallEntities 2025-01-01 2025-12-31 14140139 ns10:Audited 2025-01-01 2025-12-31 14140139 ns10:SmallCompaniesRegimeForDirectorsReport 2025-01-01 2025-12-31 14140139 ns10:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 14140139 ns10:FullAccounts 2025-01-01 2025-12-31 14140139 ns10:OrdinaryShareClass1 2025-01-01 2025-12-31 14140139 ns10:Director2 2025-01-01 2025-12-31 14140139 ns10:Director3 2025-01-01 2025-12-31 14140139 ns10:CompanySecretary1 2025-01-01 2025-12-31 14140139 ns10:RegisteredOffice 2025-01-01 2025-12-31 14140139 ns5:CurrentFinancialInstruments 2025-12-31 14140139 ns5:CurrentFinancialInstruments 2024-12-31 14140139 ns5:ShareCapital 2025-12-31 14140139 ns5:ShareCapital 2024-12-31 14140139 ns5:RetainedEarningsAccumulatedLosses 2025-12-31 14140139 ns5:RetainedEarningsAccumulatedLosses 2024-12-31 14140139 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-12-31 14140139 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-12-31 14140139 ns10:OrdinaryShareClass1 2025-12-31

REGISTERED NUMBER: 14140139 (England and Wales)

| Financial Statements |

| for the Year Ended 31 December 2025 |

| for |

| CellResearch Consumer Health Ltd |

CellResearch Consumer Health Ltd (Registered number: 14140139)

Contents of the Financial Statements

for the Year Ended 31 December 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 3 |

CellResearch Consumer Health Ltd

Company Information

for the Year Ended 31 December 2025

| DIRECTORS: | Lim Jiun Ivor

| Tan Boon Keat @ Gavin Tan Boon Keat

| Phan Toan Thang

| SECRETARY: | Paul Francis Gregory Binney

| REGISTERED OFFICE: | Rubis House

| Friarn Street

| Bridgwater

| Somerset

| TA6 3LH

| REGISTERED NUMBER: | 14140139 (England and Wales)

| AUDITORS: | Aspen Waite

| Chartered Certified Accountants

| Rubis House

| 15 Friarn Street

| Bridgwater

| Somerset

| TA6 3LH

CellResearch Consumer Health Ltd (Registered number: 14140139)

Balance Sheet

31 December 2025

| 31.12.25 |  | 31.12.24

| Notes | £ | £ |

CURRENT ASSETS

Debtors | 4 | 12,035 |  | 10,106 |  |

Cash at bank | 7,362 |  | 95,203 |  |

19,397 |  | 105,309 |  |

CREDITORS

Amounts falling due within one year | 5 | 27,283 |  | 106,172 |  |

NET CURRENT LIABILITIES | (7,886 | ) | (863 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | (7,886 | ) | (863 | ) |

CAPITAL AND RESERVES

Called up share capital | 6 | 100 |  | 100 |  |

Retained earnings | (7,986 | ) | (963 | ) |

SHAREHOLDERS' FUNDS | (7,886 | ) | (863 | ) |

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 August 2026 and were signed on its behalf by:

Tan Boon Keat @ Gavin Tan Boon Keat - Director

CellResearch Consumer Health Ltd (Registered number: 14140139)

Notes to the Financial Statements

for the Year Ended 31 December 2025

1. | STATUTORY INFORMATION

| CellResearch Consumer Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Going concern

| At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 3 (2024 - 3 ) .

CellResearch Consumer Health Ltd (Registered number: 14140139)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

4. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.12.25 |  | 31.12.24

£ | £ |

| Trade debtors | 1,263 |  | 522 |  |

| Amount owed by Ultimate Holding company | 10,262 |  | 9,205 |  |

| Other debtors | 510 |  | 379 |  |

12,035 |  | 10,106 |  |

5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.12.25 |  | 31.12.24

£ | £ |

| Trade creditors | 327 |  | 476 |  |

| Amount owed to Immediate Holding company | 23,656 |  | 104,296 |  |

| Accruals | 3,300 |  | 1,400 |  |

27,283 |  | 106,172 |  |

6. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 31.12.25 |  | 31.12.24

| value: | £ | £ |

| 100 | Ordinary | 1 | 100 |  | 100 |  |

7. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

| The Report of the Auditors was unqualified.

| Paul David Waite (Senior Statutory Auditor)

| for and on behalf of Aspen Waite

8. | ULTIMATE CONTROLLING PARTY

| The company's immediate holding company is CellResearch Consumer Health Pte. Limited, a company incorporated and domiciled in Singapore.

| The company's ultimate holding company is CellResearch Corporation Pte. Limited.

| The address and principal place of business of the immediate and ultimate holding companies is located at 137 Market Street, #14-01 Grace Global Raffles, Singapore 048953.

| Consolidated accounts are submitted by the parent company and can be found using the company name and address above.